Finding its rhythm: Startup seeks $4M in funding for trailblazing atrial fibrillation treatment
A new Ottawa biotech startup is seeking to raise $4 million to produce groundbreaking treatments aimed at curing one of the most common heart rhythm
Skip to content
Dr. Darryl Davis
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
EXPERT BLOGS
10 essential considerations when selling your business
Gobel, Sampson & Associates Private Wealth Management
